Sobi

KEPIVANCE

Manufacturer:

Sobi

Kepivance HCPCS:

J2425

HCPCS Code Descriptor:

Injection, palifermin, 50 micrograms

Category:

J Code

Kepivance NDCs:

66658-0113-06, 66658-0113-03

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Kepivance:

KEPIVANCE is an Oncology drug manufactured by Sobi and administered via the Intravenous route of administration. The J Code: J2425 is aligned to the drug KEPIVANCE.

ACCESS PRICING AND MORE BY REGISTERING

J2425 Added Date:

January 1, 2006

J2425 Effective Date:

January 1, 2006

J2425 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Kepivance billing and coding information.
Our team did not identify a source for Kepivance patient assistance information. Please reach out to our team if you feel that this is a mistake.
KEPIVANCE prescribing information can be found at the link below:
Information regarding KEPIVANCE’s side effects can be found at MedlinePlus